Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(Suppl):S220-S227. Published online November 10, 2022

DOI: https://doi.org/10.3350/cmh.2022.0360

View: 3341 Download: 130 Web of Science: 2 Crossref: 2

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease

Karim Seif El Dahan, Darine Daher, Amit G. Singal

Clin Mol Hepatol. 2023;29(Suppl):S207-S219. Published online September 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0247

View: 7085 Download: 160 Web of Science: 4 Crossref: 6

Editorial

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?

Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang

Clin Mol Hepatol. 2023;29(2):404-407. Published online March 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0069

View: 2552 Download: 70 Web of Science: 2 Crossref: 2

The imitator of immune-tolerant chronic hepatitis B: A killer in disguise

Moon Haeng Hur, Jeong-Hoon Lee

Clin Mol Hepatol. 2023;29(2):363-366. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0079

View: 2503 Download: 83 Web of Science: 1 Crossref: 1

Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap

Shen-Yung Wang

Clin Mol Hepatol. 2023;29(2):349-351. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0082

View: 2358 Download: 57

What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?

Min Kyung Park, Yoon Jun Kim

Clin Mol Hepatol. 2023;29(2):332-334. Published online March 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0080

View: 2309 Download: 47

Review

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective

Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu

Clin Mol Hepatol. 2023;29(2):230-241. Published online January 30, 2023

DOI: https://doi.org/10.3350/cmh.2022.0421

View: 5170 Download: 350 Web of Science: 8 Crossref: 8

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective

Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi

Clin Mol Hepatol. 2023;29(2):197-205. Published online January 5, 2023

DOI: https://doi.org/10.3350/cmh.2022.0404

View: 4050 Download: 222 Web of Science: 10 Crossref: 9

Original Article

Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease

Won Sohn, Danbee Kang, Minwoong Kang, Eliseo Guallar, Juhee Cho, Yong-Han Paik

Clin Mol Hepatol. 2022;28(4):851-863. Published online June 3, 2022

DOI: https://doi.org/10.3350/cmh.2022.0037

View: 4417 Download: 195 Web of Science: 19 Crossref: 17

Editorial

Surveillance for hepatocellular carcinoma: It is time to move forward

Bo Hyun Kim, Yuri Cho, Joong-Won Park

Clin Mol Hepatol. 2022;28(4):810-813. Published online September 6, 2022

DOI: https://doi.org/10.3350/cmh.2022.0257

View: 2782 Download: 88 Web of Science: 5 Crossref: 5

Original Article

Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B

Lilian Yan Liang, Hye Won Lee, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vicki Wing-Ki Hui, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong

Clin Mol Hepatol. 2021;27(3):499-509. Published online February 26, 2021

DOI: https://doi.org/10.3350/cmh.2020.0333

View: 4519 Download: 134 Web of Science: 14 Crossref: 14

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance

Jeong Won Jang, Jin Seoub Kim, Hye Seon Kim, Kwon Yong Tak, Heechul Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Lewis R. Roberts

Clin Mol Hepatol. 2021;27(1):207-218. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0115

View: 6339 Download: 247 Web of Science: 22 Crossref: 21

Letter to the Editor

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?

Bo Hyun Kim

Clin Mol Hepatol. 2020;26(4):579-581. Published online September 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0200

View: 3564 Download: 72 Web of Science: 2 Crossref: 2

Editorial

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?

Ju Hyun Shim

Clin Mol Hepatol. 2020;26(2):183-184. Published online March 12, 2020

DOI: https://doi.org/10.3350/cmh.2020.0042

View: 4205 Download: 111 Web of Science: 6 Crossref: 6

Review

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?

Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal

Clin Mol Hepatol. 2019;25(3):264-269. Published online March 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.1001

View: 9637 Download: 325 Web of Science: 47 Crossref: 47

Original Article

Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?

Linda L. Wong, Ruel J. Reyes, Sandi A. Kwee, Brenda Y. Hernandez, Sumodh C. Kalathil, Naoky C. Tsai

Clin Mol Hepatol. 2017;23(3):239-248. Published online July 14, 2017

DOI: https://doi.org/10.3350/cmh.2017.0008

View: 7757 Download: 143 Web of Science: 32 Crossref: 34

Editorial

Surveillance of hepatocellular carcinoma: is only ultrasound enough?

Woo Kyoung Jeong

Clin Mol Hepatol. 2017;23(3):222-223. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0046

View: 6515 Download: 162 Web of Science: 7 Crossref: 6

Original Article

A lexicon for hepatocellular carcinoma surveillance ultrasonography: benign versus malignant lesions

Chansik An, Gulbahor Rakhmonova, Kyunghwa Han, Nieun Seo, Jin Young Lee, Myeong-Jin Kim, Mi-Suk Park

Clin Mol Hepatol. 2017;23(1):57-65. Published online March 24, 2017

DOI: https://doi.org/10.3350/cmh.2016.0041

View: 14133 Download: 190 Web of Science: 2 Crossref: 2

Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park

Clin Mol Hepatol. 2015;21(3):279-286. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.279

View: 12910 Download: 146 Web of Science: 59 Crossref: 58

3

Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein Level?

Woo Young Shin, M.D., Kyung-Suk Suh, M.D. Taehoon Kim, M.D. Young Min Jeon, M.D. Nam-Joon Yi, M.D. Kuhn Uk Lee, M.D.

Clin Mol Hepatol. 2010;16(2):168-175. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.168

View: 4430 Download: 19 Crossref: 3

Review

Unmet needs in the post-DAA era: the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication

Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu

Received March 1, 2024 Accepted April 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.0155 [Accepted]

View: 178 Download: 12

1 |

Viewed By 5544	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4741	MAFLD: How is it different from NAFLD?
Viewed By 4469	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3664	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3638	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search